Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
110.50
-0.36 (-0.32%)
At close: Nov 21, 2024, 4:00 PM
110.98
+0.48 (0.43%)
After-hours: Nov 21, 2024, 4:44 PM EST
Sarepta Therapeutics Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for SRPT stock have an average target of 182, with a low estimate of 109 and a high estimate of 230. The average target predicts an increase of 64.71% from the current stock price of 110.50.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SRPT stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 7 |
| Buy | 9 | 10 | 11 | 11 | 12 | 13 |
| Hold | 4 | 3 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 20 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $148 → $150 | Strong Buy | Maintains | $148 → $150 | +35.75% | Nov 7, 2024 |
| Baird | Baird | Buy Maintains $200 → $193 | Buy | Maintains | $200 → $193 | +74.66% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $152 → $167 | Hold → Buy | Upgrades | $152 → $167 | +51.13% | Nov 7, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $179 → $170 | Buy | Maintains | $179 → $170 | +53.85% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +85.52% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
1.82B
from 1.24B
Increased by 45.98%
Revenue Next Year
3.23B
from 1.82B
Increased by 78.13%
EPS This Year
1.88
from -5.80
EPS Next Year
11.70
from 1.88
Increased by 521.43%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.0B | 3.9B | 4.5B | ||
| Avg | 1.8B | 3.2B | 3.8B | ||
| Low | 1.3B | 2.9B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 58.4% | 117.5% | 40.6% | ||
| Avg | 46.0% | 78.1% | 18.3% | ||
| Low | 6.0% | 62.0% | -48.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.42 | 18.43 | 20.34 | ||
| Avg | 1.88 | 11.70 | 14.15 | ||
| Low | 0.26 | 7.09 | 8.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 879.0% | 73.8% | ||
| Avg | - | 521.4% | 20.9% | ||
| Low | - | 276.3% | -28.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.